The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
Roots
Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention
Services Marker, 2019-2030.”
The report offers a comprehensive study of
the current scenario and future potential of the players providing patient
enrollment and retention services. The study features an in-depth analysis,
highlighting the capabilities of the various stakeholders in this domain. In
addition to other elements, the study includes:
§ A
detailed assessment of the current market landscape of companies offering patient recruitment and retention services.
§ An
analysis of the most active regions (in terms of patient recruitment activity)
engaged in this domain, featuring schematic world map representations that
highlight key hubs across the globe.
§ An
insightful 2X2 representation of the results of a competitiveness analysis of
various service providers highlighting capable players in this domain, based on
their respective capabilities.
§ Comprehensive
profiles of patient recruitment and retention service
providers (shortlisted on the basis of the number of services).
§ An
analysis of the partnerships that have been established in this domain, in the
recent past
§ A
review of emerging trends in the industry to overcome the challenges associated
with patient recruitment and retention
§ A
detailed market forecast, featuring analysis of the current and projected
future opportunity across key market segments (listed below)
§ Therapeutic
Area
§ Oncology
§ Infectious
Diseases
§ Cardiovascular
Diseases
§ CNS
Disorders
§ Respiratory
Disorders
§ Metabolic
Disorders
§ Others
§ Steps
in Patient Recruitment Process
§ Pre-screening
§ Screening
§ Phase
of Development
§ Phase
I
§ Phase
II
§ Phase
III
§ Phase
IV
§ Key
Geographical Region
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the world
To request a sample copy / brochure of this
report, please visit this
https://www.rootsanalysis.com/reports/245/request-sample.html
Transcripts of interviews held with the
following senior level representatives of stakeholder companies
§ Simon
Klaasen, Co-founder and Managing Director, Link2Trials
§ Hagit
Nof, Chief Operation Officer and Business Development Officer, nRollmed
§ Paul
Ivsin, Managing Director, Seeker Health
Key companies covered in the report
§ Acurian
§ BBK Worldwide
§ Bright Pharmaceuticals Services
§ ClinEdge
§ CSSi
§ CTM
§ FIDELIS RESEARCH
§ Ignite Data
§ Integrated Clinical Trial Services
§ MMG
§ Pacific Groove
§ Polaris BioPharma Consulting
§ Topstone Research
§ TrialWire
§ Tudor Reilly Health
§ WCCT Global
For more information please click on the
following link:
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben
Johnson
+1
(415) 800 3415
+44
(122) 391 1091
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
Comments
Post a Comment